Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is a leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, equal to 300% of the performance of the S&P Pharmaceuticals Select Industry Index, a modified equal-weighted index measuring pharmaceutical and medical stocks within the S&P Total Market Index classified under the GICS pharmaceuticals sub-industry. The fund provides exposure through financial instruments including swaps, futures, and holdings in pharmaceutical companies such as Royalty Pharma, Corcept Therapeutics, Elanco Animal Health, Viatris, Pfizer, Merck & Company, Johnson & Johnson, Tarsus Pharmaceuticals, Perrigo, and Axsome Therapeutics; it also invests in treasury instruments, cash management funds, and index swaps for leverage and liquidity. Launched on November 15, 2017, and listed on NYSE Arca, PILL is issued by Direxion Shares ETF Trust and managed by Rafferty Asset Management, LLC, with headquarters in Alexandria, Virginia, and operates primarily in the U.S. market targeting sophisticated investors seeking short-term leveraged bullish exposure to the pharmaceuticals sector. The fund maintains a net expense ratio of 0.97% through September 1, 2026, under an operating expense limitation agreement, with recent assets under management around $12 million and quarterly income distributions including $0.02449 in June 2025, $0.01829 in March 2025, and $0.01305 in December 2024. In January 2024, Direxion introduced a new ETF Alert Service for price and volume notifications via text message, enhancing operational tools for traders amid ongoing market volatility.